|
Fig. 14.5 A, Hydroxychloroquineinduced slate-gray pigmentation of the buccal mucosa. B, Minocycline-induced slate-gray pigment of lower legs. The minocycline is complexed with the extravascular hemosiderin from stasis dermatitis, which accounts for the distinctive distribution. (Courtesy of the Fitzsimons Army Medical Center teaching files.) |
Drugs produce cutaneous hyperpigmentation and discoloration by different mechanisms. The two main mechanisms of hyperpigmentation and discoloration are drug deposition (e.g., heavy metals) and stimulation of melanocytic activity (Table 14-2; Fig. 14-5).
Table 14-2. Drugs Producing Changes in Skin Pigmentation |
| COLOR | | DRUG |
| Slate-gray | | Chloroquine Hydroxychloroquine (see Fig. 14-5A) Minocycline (see Fig. 14-5B) Phenothiazines |
| Slate-blue | | Amiodarone |
| Blue-gray | | Gold (chrysoderma) |
| Yellow | | Beta-carotene Quinacrine |
| Red | | Clofazimine |
| Brown (hyperpigmentation) | | Adrenocorticotropic hormone (ACTH) Bleomycin Oral contraceptives Zidovudine |
| | | |